Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model

Total article views   HTML views PDF downloads Totals
5,135 Dovepress* 4,939+ 160 5,099
PubMed Central* 196 87 283
Totals 5,135 247 5,382
*Since 13 November 2021

View citations on PubMed Central and Google Scholar